Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patient characteristics

From: First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9

Patient Age (years) BMI (kg/m2) Gleason score PSA (ng/ml) PSA doubling time (months) 68Ga-MJ9 PET/CT findings
1 62 31.4 9 8.5 2 Lymph nodes + bone metastases
2a 68 22.1 7 2.3 1 Bone metastases
3b 67 27.5 6 3.4 18 Bone metastases
4b 72 24.9 9 7.7 4.4 Lymph-nodal metastases
5 56 24.3 8 7.3 12 Local relapse
  1. aHistory of pancreatic carcinoma treated with pancreaticoduodenectomy, and adjuvant chemo- and radiotherapy
  2. bHistory of gallstones treated with cholecystectomy